Free Trial
ASX:PME

Pro Medicus (PME) Stock Price, News & Analysis

Pro Medicus logo

About Pro Medicus Stock (ASX:PME)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
285,954 shs
Average Volume
N/A
Market Capitalization
A$29.16 billion
P/E Ratio
351.99
Dividend Yield
0.14%
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive PME Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Pro Medicus and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

PME Stock News Headlines

An $8 trillion-dollar discovery 17,000 ft underwater
A strange rock pulled from the ocean floor may hold the key to a $16 trillion resource boom. Inside it: materials critical for AI chips, EV batteries, smartphones, and advanced weapons systems. While few people know about these metals, global powers—including the U.S., China, and Russia—are racing to secure them. And one tiny public company, recently backed by the U.S. government, holds mining rights to over 340 million tons… and near-monopoly access to the richest zone.tc pixel
Pro Medicus Limited Announces Cessation of Securities
Investors overly optimistic on ASX highflyer
See More Headlines

PME Stock Analysis - Frequently Asked Questions

Based on aggregate information from My MarketBeat watchlists, some other companies that Pro Medicus investors own include Mineral Resources (MIN), ResMed (RMD), Technology One (TNE), ARB (ARB), Accent Group (AX1), Cochlear (COH) and CSL (CSL).

Company Calendar

Today
8/28/2025
Ex-Dividend for 9/24 Dividend
9/02/2025
Record date for 9/24 Dividend
9/24/2025
Dividend Payable
9/24/2025

Industry, Sector and Symbol

Stock Exchange
ASX
Sector
Medical
Industry
Health Information Services
Sub-Industry
N/A
Current Symbol
ASX:PME
CIK
N/A
Fax
N/A
Employees
2,060
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
A$0.78
Trailing P/E Ratio
351.99
Forward P/E Ratio
N/A
P/E Growth
3.87
Net Income
A$82.79 million
Net Margins
51.27%
Pretax Margin
N/A
Return on Equity
47.73%
Return on Assets
30.68%

Debt

Debt-to-Equity Ratio
1.10
Current Ratio
5.98
Quick Ratio
4.39

Sales & Book Value

Annual Sales
A$161.50 million
Price / Sales
0.00
Cash Flow
N/A
Price / Cash Flow
71.76
Book Value
A$1.80 per share
Price / Book
N/A

Miscellaneous

Outstanding Shares
104,500,000
Free Float
N/A
Market Cap
A$29.16 billion
Optionable
Not Optionable
Beta
0.56
These 7 Stocks Will Be Magnificent in 2025 Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report

This page (ASX:PME) was last updated on 8/28/2025 by MarketBeat.com Staff
From Our Partners